Jefferies maintained a Buy rating on Merck & Co., citing revenue growth from Keytruda and vaccine sales stability.

1 report, 0 independent Updated Jun 25

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

SpeculativeNo independent reporting found

Who's involved

What this event is mainly about

Merck KGaA

Keep exploring

Part of

Market growth is being driven by advanced therapies involving Pfizer, Novartis, and Merck. All 2 developments

Within Market growth is being driven by advanced therapies involving Pfizer, Novartis, and Merck.

The entities involved

Merck KGaA
German multinational science and technology company
- MSD, which operates as Merck & Co. in the US and Canada, has appointed Vidhya as Associate Vice President.Mon 12:02
- Merck KGaA filed required 13F reports with the Securities and Exchange Commission regarding institutional holdings on June 15, 2026.Mon 02:05

Coverage

Newest first; wire copies grouped

Jun 25Unknown outlet